Daniela is a Senior Advisor at HealthTech180. She is an MD specialised in Infectious diseases. After a long-standing experience in the clinical and research field, she joined the pharmaceutical industry, serving in different roles "from medical affairs to clinical research" of increasing responsibility, with extensive involvement in regulatory and market access activities.
Currently, she is Executive Director, Clinical R&D, at F2G.
She also works as an External Expert Evaluator of the European Commission.
Daniela is a passionate scientist, clinical researcher and business leader, with the main goal to bring effective solutions to clinicians and to the most in need patients.
She is the co-author of a number of publications on peer-reviewed scientific journals, mainly in the field of antivirals and antimicrobials in general.
||Antivirals, Antifungals and Antimicrobials